Financial News

Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

10x Genomics, Inc. - Common Stock (NQ:TXG)

11.01 +0.60 (+5.76%)
Streaming Delayed Price Updated: 4:00 PM EDT, Jun 16, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about 10x Genomics, Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 8 9 Next >
Recap: 10x Genomics Q4 Earnings
10x Genomics (NASDAQ:TXG) reported its Q4 earnings results on Wednesday, February 16, 2022 at 04:05 PM. Here's what investors need to know about the announcement. 
Via Benzinga
The Daily Biotech Pulse: Avenue Tumbles On Negative Adcom Verdict, Moderna's Expanded Deal With Rovi, Gilead Takes Equity Stake In Hookipa
Here's a roundup of top developments in the biotech space over the last 24 hours. Stocks In Focus Hookipa Gets $15M Upfront Payment And Equity Investment From Gilead Following... 
Via Benzinga
Earnings Scheduled For February 16, 2022
Companies Reporting Before The Bell • Wix.com (NASDAQ:WIX) is projected to report quarterly loss at $0.38 per share on revenue of $331.16 million. 
Via Benzinga
A Preview Of 10x Genomics's Earnings
10x Genomics (NASDAQ:TXG) is set to give its latest quarterly earnings report on Wednesday, 2022-02-16. Here's what investors need to know before the announcement. Analysts estimate that 10x Genomics... 
Via Benzinga
7 Stocks to Love for a Long, Long Time
Although there are plenty of risks abound due to monetary and geopolitical pressures, there are discounts to be had for stocks to love. 
Via InvestorPlace
The Daily Biotech Pulse: Pfizer, Bristol-Myers Squibb Earnings, Amgen Goes Shopping, GlaxoSmithKline-Vir's COVID-19 Antibody Treatment Supply Deal
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs July 27) Bio-Rad Laboratories, Inc... 
Via Benzinga
Exposures COVID-19
The Week Ahead In Biotech (Feb. 13-19): Agios FDA Meeting, Avenue Adcom, Earnings And More
Biotech stocks moved back and forth amid some volatility before finishing the week ending Feb. 11 modestly lower, reversing the gains from the previous week. Earnings news... 
Via Benzinga
10 Health Care Stocks Whale Activity In Today's Session
This whale alert can help traders discover the next big trading opportunities. Whales are entities with large sums of money and we track their transactions here at Benzinga on our... 
Via Benzinga
FedEx Options Trade & Stock Analysis
This week we discuss last week's performance of our trades in the NUGT ETF. We also review our trade of FedEx after recent earnings. 
Via Talk Markets
Stocks That Hit 52-Week Lows On Friday
During Friday's session, 445 companies made new 52-week lows. Noteable 52-Week Lows: Intuitive Surgical (NASDAQ:ISRG) is the largest company in terms of market cap to... 
Via Benzinga
52 Weeks High And Low Article
Stocks that Broke Yearly Lows Tuesday Morning During Tuesday's morning trading, 87 companies set new 52-week lows. Noteworthy Highlights From Today's 52-Week Highs And Lows: 10x... 
Via Benzinga
10x Genomics Stock: Bull vs. Bear
After a hot start, the stock has recently lagged the market. Is now a good time to buy? 
Via The Motley Fool
Topics Initial Public Offering
Exposures Securities Market
Stocks That Hit 52-Week Lows On Thursday
On Thursday, 615 stocks hit new 52-week lows. Noteable 52-Week Lows: Sea (NYSE:SE) is the largest company in terms of market cap to set a new 52-week low this... 
Via Benzinga
Notable 10X Genomics Insider Trades $2.8M In Company Stock
Bradford Crutchfield, Insider at 10X Genomics (NASDAQ:TXG), made a large buy and sell of company shares on November 12, according to a new SEC filing. What Happened: A Form 4... 
Via Benzinga
Topics Regulatory Compliance
Exposures Legal Regulatory
Better Buy: 10x Genomics vs. DermTech
Both companies offer disruptive new solutions in their niches of the healthcare space. 
Via The Motley Fool
Chief Executive Officer Of 10X Genomics Trades $2.5M In Company Stock
Serge Saxonov, Chief Executive Officer at 10X Genomics (NASDAQ:TXG), made a large buy and sell of company shares on November 2, according to a new SEC filing. What Happened: A... 
Via Benzinga
Topics Regulatory Compliance
Exposures Legal Regulatory
10x Genomics Clocks 74% Jump In Q3 Revenues; Raises Top End Of Sales Guidance
10x Genomics Inc (NASDAQ: TXG) reported Q3 sales of $125.3 million, beating the consensus of $122.62 million. Sales increased 74% Y/Y, primarily due to increased... 
Via Benzinga
10X Genomics Inc (TXG) Q3 2021 Earnings Call Transcript
TXG earnings call for the period ending September 30, 2021. 
Via The Motley Fool
Topics Earnings
Exposures Financial
The Daily Biotech Pulse: Cerus Climbs On Earnings, Horizon CFO To Retire, Teva Prices Upsized Sustainability-Linked Senior Note Offering
Here's a roundup of top developments in the biotech space over the last 24 hours. Stocks In Focus Horizon Announces Retirement Of CFO, Beat-and-raise Q3 Horizon Therapeutics... 
Via Benzinga
Topics Retirement
Exposures Pension
Earnings Preview: 10x Genomics
10x Genomics (NASDAQ:TXG) is set to give its latest quarterly earnings report on Wednesday, 2021-11-03. Here's what investors need to know before the announcement. Analysts... 
Via Benzinga
Notable 10X Genomics Insider Trades $2.7M In Company Stock
Bradford Crutchfield, Chief Commercial Officer at 10X Genomics (NASDAQ:TXG), made a large buy and sell of company shares on October 12, according to a new SEC filing. What... 
Via Benzinga
Topics Regulatory Compliance
Exposures Legal Regulatory
3 COVID Stocks That Can Turn $1,000 Into $10,000
Our trio of contributors offer three COVID-19 stocks that will zoom higher, even as we emerge from the pandemic. 
Via The Motley Fool
Exposures COVID-19
Earnings Scheduled For November 3, 2021
Companies Reporting Before The Bell • R.R.Donnelley & Sons (NYSE:RRD) is likely to report quarterly earnings at $0.32 per share on revenue of $1.19 billion.... 
Via Benzinga
The Week Ahead In Biotech (Oct. 31-Nov. 6): Earnings Pick Up Pace, Eton Awaits Seizure Drug Approval, Kidney Conference, More IPOs In The Pipeline
Biotech stocks rose a third week running in the week ending Oct. 29 amid positive reaction to earnings. Big pharma earnings were mostly better than expected. Merck & Co, Inc... 
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For September 16, 2021
Upgrades For Signet Jewelers Ltd (NYSE: 
Via Benzinga
Why 10x Genomics Shares Are Trading Lower Today
10x Genomics (NASDAQ:TXG) shares are trading lower after B of A Securities downgraded the stock from Buy to Neutral and announced a $180 price target. 10x Genomics' stock... 
Via Benzinga
12 Health Care Stocks Moving In Wednesday's After-Market Session
Gainers Scopus BioPharma (NASDAQ:SCPS) s... 
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For September 14, 2021
Upgrades Northcoast Research upgraded the previous rating for Casey's General Stores Inc ... 
Via Benzinga
Earnings Scheduled For August 5, 2021
Companies Reporting Before The Bell • OneSpaWorld Holdings (NASDAQ:OSW) is projected to report quarterly loss at $0.20 per share on revenue of $6.42 million. •... 
Via Benzinga
Earnings Scheduled For August 4, 2021
Companies Reporting Before The Bell • UroGen Pharma (NASDAQ:URGN) is projected to report earnings for its second quarter. • Vericel (NASDAQ:VCEL) is expected to... 
Via Benzinga
< Previous 1 2 3 4 5 6 7 8 9 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.

Use the myMotherLode.com Keyword Search to go straight to a specific page

Popular Pages

  • Local News
  • US News
  • Weather
  • State News
  • Events
  • Traffic
  • Sports
  • Dining Guide
  • Real Estate
  • Classifieds
  • Financial News
  • Fire Info
Terms of Service Privacy Policy
© Copyright 2000-2019 Clarke Broadcasting Corporation. All rights reserved.
Feedback